• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

Recent Advances in the Application of 3,5-Bis(chlorosulfonyl)benzoic Acid (CAS: 21829-31-2) in Chemical Biology and Pharmaceutical Research

3,5-Bis(chlorosulfonyl)benzoic Acid (CAS: 21829-31-2) is a highly reactive sulfonyl chloride derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including sulfonamide-based drugs, enzyme inhibitors, and fluorescent probes. Its unique chemical properties, such as the presence of two chlorosulfonyl groups and a carboxylic acid moiety, enable it to participate in diverse chemical reactions, making it a valuable tool for medicinal chemists and chemical biologists.

Recent studies have explored the use of 3,5-Bis(chlorosulfonyl)benzoic Acid in the development of novel sulfonamide-based therapeutics. Sulfonamides are a well-established class of drugs with broad-spectrum antibacterial, antiviral, and anticancer activities. Researchers have leveraged the reactivity of this compound to synthesize sulfonamide derivatives that target specific enzymes involved in disease pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the successful incorporation of 3,5-Bis(chlorosulfonyl)benzoic Acid into a series of carbonic anhydrase inhibitors, which showed promising activity against hypoxic tumors.

In addition to its role in drug development, 3,5-Bis(chlorosulfonyl)benzoic Acid has been employed in the design of chemical probes for studying biological systems. Its ability to form stable covalent bonds with nucleophilic amino acids, such as lysine and cysteine, makes it an ideal candidate for activity-based protein profiling (ABPP). A recent study in ACS Chemical Biology utilized this compound to develop a sulfonyl fluoride probe that selectively labels active sites of serine hydrolases, providing insights into enzyme function and inhibitor discovery.

The synthesis and scale-up of 3,5-Bis(chlorosulfonyl)benzoic Acid have also seen advancements. Traditional methods involving the chlorosulfonation of benzoic acid derivatives often suffer from low yields and poor selectivity. However, a 2022 publication in Organic Process Research & Development reported an optimized procedure using controlled reaction conditions and advanced purification techniques, achieving higher yields and purity suitable for industrial-scale production. This development is particularly significant for pharmaceutical companies looking to incorporate this intermediate into large-scale drug manufacturing processes.

Looking ahead, researchers are exploring new applications of 3,5-Bis(chlorosulfonyl)benzoic Acid in emerging areas such as targeted protein degradation and covalent drug discovery. Its dual functionality allows for the creation of bifunctional molecules that can simultaneously engage with target proteins and E3 ubiquitin ligases, paving the way for novel therapeutic strategies. As the field of chemical biology continues to evolve, this compound is expected to play an increasingly important role in bridging the gap between synthetic chemistry and biological research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)